CHICAGO, Nov. 4, 2026 /PRNewswire/ -- Belay Diagnostics, a molecular diagnostics company specializing in cerebrospinal fluid (CSF) liquid biopsy testing for central nervous system (CNS) cancers, announced today that its team won Palantir's Foundry for Builders Buildcamp for the second consecutive year.
PR Newswire Business Technology ·